- Home
- IPHA vs SBFG Comparison
IPHA vs SBFG Comparison
Compare IPHA & SBFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- SBFG
- Stock Information
- Founded
- IPHA 1999
- SBFG 1983
- Country
- IPHA France
- SBFG United States
- Employees
- IPHA N/A
- SBFG N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- SBFG Major Banks
- Sector
- IPHA Health Care
- SBFG Finance
- Exchange
- IPHA Nasdaq
- SBFG Nasdaq
- Market Cap
- IPHA 160.1M
- SBFG 155.9M
- IPO Year
- IPHA 2019
- SBFG N/A
- Fundamental
- Price
- IPHA $1.97
- SBFG $18.71
- Analyst Decision
- IPHA Strong Buy
- SBFG
- Analyst Count
- IPHA 1
- SBFG 0
- Target Price
- IPHA $11.50
- SBFG N/A
- AVG Volume (30 Days)
- IPHA 28.5K
- SBFG 16.4K
- Earning Date
- IPHA 03-27-2025
- SBFG 05-01-2025
- Dividend Yield
- IPHA N/A
- SBFG 3.08%
- EPS Growth
- IPHA N/A
- SBFG N/A
- EPS
- IPHA N/A
- SBFG 1.72
- Revenue
- IPHA $20,831,349.00
- SBFG $56,774,000.00
- Revenue This Year
- IPHA $220.44
- SBFG N/A
- Revenue Next Year
- IPHA $81.85
- SBFG N/A
- P/E Ratio
- IPHA N/A
- SBFG $10.90
- Revenue Growth
- IPHA N/A
- SBFG 0.08
- 52 Week Low
- IPHA $1.29
- SBFG $13.01
- 52 Week High
- IPHA $3.51
- SBFG $24.48
- Technical
- Relative Strength Index (RSI)
- IPHA 53.30
- SBFG 41.54
- Support Level
- IPHA $1.81
- SBFG $17.33
- Resistance Level
- IPHA $2.00
- SBFG $18.95
- Average True Range (ATR)
- IPHA 0.14
- SBFG 0.90
- MACD
- IPHA 0.02
- SBFG -0.08
- Stochastic Oscillator
- IPHA 53.76
- SBFG 36.41
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About SBFG SB Financial Group Inc.
SB Financial Group Inc operates as a Holding Company of State Bank and RDSI/DCM. Its activities involve commercial banking, trust, and financial services. It offers a full-range of financial services for consumers and small businesses, including trust services, mortgage banking, wealth management services, commercial and agricultural lending. It accepts deposits, such as checking accounts, savings accounts, money market accounts, demand deposits, and time certificates of deposit. It earns revenue in the form of interest income.